|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Methyl parathion |
CAS 298-00-0 | ||
(CH3O)2P(S)OC6H4NO2 |
RTECS TG0175000 | ||
|
Synonyms & Trade Names Azophos®; O,O-Dimethyl-O-p-nitrophenylphosphorothioate; Parathion methyl |
DOT ID & Guide 2783 152 (solid) 3018 152 (liquid) |
||
Exposure
|
NIOSH REL: TWA 0.2 mg/m3 [skin] | ||
| OSHA PEL†: none | |||
| IDLH N.D. See: IDLH INDEX | Conversion | ||
|
Physical Description White to tan, crystalline solid or powder with a pungent, garlic-like odor. [pesticide] [Note: The commercial product in xylene is a tan liquid.] |
|||
|
MW: 263.2 |
BP: 289°F |
MLT: 99°F |
Sol(77°F): 0.006% |
|
VP: 0.00001 mmHg |
IP: ? |
|
Sp.Gr: 1.36 |
|
Fl.P: ? |
UEL: ? |
LEL: ? |
|
| Combustible Solid | |||
|
Incompatibilities & Reactivities Strong oxidizers, water [Note: Explosive risk when heated above 122°F.] |
|||
|
Measurement Methods NIOSH 5600; OSHA PV2112 See: NMAM or OSHA Methods |
|
Personal Protection & Sanitation (See protection) Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated/Daily Remove: When wet or contaminated Change: Daily Provide: Eyewash, Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
|
Important additional information about respirator selection Respirator Recommendations NIOSH Up to 2 mg/m3: (APF = 10) Any air-purifying half-mask respirator with organic vapor cartridge(s) in combination with an N95, R95, or P95 filter. The following filters may also be used: N99, R99, P99, N100, R100, P100. Click here for information on selection of N, R, or P filters. (APF = 10) Any supplied-air respirator Up to 5 mg/m3: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode (APF = 25) Any powered air-purifying respirator with an organic vapor cartridge in combination with a high-efficiency particulate filter. Up to 10 mg/m3: (APF = 50) Any air-purifying full-facepiece respirator equipped with organic vapor cartridge(s) in combination with an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters. (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters. (APF = 50) Any powered, air-purifying respirator with a tight-fitting facepiece and organic vapor cartridge(s) in combination with a high-efficiency particulate filter (APF = 50) Any supplied-air respirator that has a tight-fitting facepiece and is operated in a continuous-flow mode (APF = 50) Any self-contained breathing apparatus with a full facepiece (APF = 50) Any supplied-air respirator with a full facepiece Up to 200 mg/m3: (APF = 2000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode (APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus |
|
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; nausea, vomiting, abdominal cramps, diarrhea, salivation; headache, dizziness, lassitude (weakness, exhaustion); rhinorrhea (discharge of thin mucus), chest tightness; blurred vision, miosis; cardiac irregularities; muscle fasciculation; dyspnea (breathing difficulty) | |
|
Target Organs
Eyes, skin, respiratory system, central nervous system, cardiovascular system, blood cholinesterase |
|
| See also: INTRODUCTION See ICSC CARD: 0626 |